BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9852715)

  • 1. [Effect of matrix metalloproteinase inhibitor on experimental pseudomonal corneal ulceration].
    Kosaku K; Maeda N; Yokoyama T; Inoue T; Yoshida Y; Hosokawa T; Sawa M
    Nippon Ganka Gakkai Zasshi; 1998 Nov; 102(11):717-23. PubMed ID: 9852715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor.
    Barletta JP; Angella G; Balch KC; Dimova HG; Stern GA; Moser MT; van Setten GB; Schultz GS
    Invest Ophthalmol Vis Sci; 1996 Jan; 37(1):20-8. PubMed ID: 8550324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of matrix metalloproteinase inhibitor on pseudomonal proteinases].
    Kosaku K; Maeda N; Yokoyama T; Inoue T; Yoshida Y; Hosokawa T; Sawa M
    Nippon Ganka Gakkai Zasshi; 1998 Feb; 102(2):83-7. PubMed ID: 9513352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a synthetic metalloproteinase inhibitor on corneal ulceration in alkali burns and pseudomonas keratitis.
    Burns FR; Gray RD; Wells JT; Paterson CA
    Matrix Suppl; 1992; 1():317-8. PubMed ID: 1480049
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis.
    Ikema K; Matsumoto K; Inomata Y; Komohara Y; Miyajima S; Takeya M; Tanihara H
    Exp Eye Res; 2006 Dec; 83(6):1396-404. PubMed ID: 16968651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vitamin A deficiency on the early response to experimental Pseudomonas keratitis.
    Twining SS; Zhou X; Schulte DP; Wilson PM; Fish B; Moulder J
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):511-22. PubMed ID: 8595951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of peptide-based matrix metalloproteinase inhibitors in corneal ulceration.
    Gray RD; Paterson CA
    Ann N Y Acad Sci; 1994 Sep; 732():206-16. PubMed ID: 7978792
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of a metalloproteinase inhibitor on established corneal ulcers after an alkali burn.
    Wentworth JS; Paterson CA; Gray RD
    Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2174-9. PubMed ID: 1607227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases induction by pseudomonal virulence factors and inflammatory cytokines in vitro.
    Miyajima S; Akaike T; Matsumoto K; Okamoto T; Yoshitake J; Hayashida K; Negi A; Maeda H
    Microb Pathog; 2001 Dec; 31(6):271-81. PubMed ID: 11747375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix Metalloproteinase-13 as a Target for Suppressing Corneal Ulceration Caused by Pseudomonas aeruginosa Infection.
    Gao N; Kumar A; Yu FS
    J Infect Dis; 2015 Jul; 212(1):116-27. PubMed ID: 25589337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of matrix metalloproteinase concentrations in precorneal tear film from dogs with Pseudomonas aeruginosa-associated keratitis.
    Wang L; Pan Q; Xue Q; Cui J; Qi C
    Am J Vet Res; 2008 Oct; 69(10):1341-5. PubMed ID: 18828693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of alkali-induced corneal ulceration and perforation by a thiol peptide.
    Burns FR; Gray RD; Paterson CA
    Invest Ophthalmol Vis Sci; 1990 Jan; 31(1):107-14. PubMed ID: 2153643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of systemic tetracycline on progression of Pseudomonas aeruginosa keratitis in the rabbit.
    Levy JH; Katz HR
    Ann Ophthalmol; 1990 May; 22(5):179-83. PubMed ID: 2114813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteinases of the cornea and preocular tear film.
    Ollivier FJ; Gilger BC; Barrie KP; Kallberg ME; Plummer CE; O'Reilly S; Gelatt KN; Brooks DE
    Vet Ophthalmol; 2007; 10(4):199-206. PubMed ID: 17565550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for TIMP-1 protection against P. aeruginosa-induced corneal ulceration and perforation.
    Kernacki KA; Barrett R; Hazlett LD
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3168-76. PubMed ID: 10586939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antiproteolytic agents on corneal epithelial viability and matrix metalloproteinase-2 and metalloproteinase-9 activity in alkali-burned corneas of rats.
    Piso DY; Ribeiro AP; Silva ML; Guimarães PJ; Morales A; Martins BC; Padua IM; Renzo R; Andrade AL; Uscátegui RR; Laus JL
    Vet Ophthalmol; 2014 Jan; 17(1):23-31. PubMed ID: 23433350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aprotinin treatment of pseudomonal corneal infection.
    Stuart JC; Turgeon PT; Kowalski RP
    Cornea; 1991 Jan; 10(1):63-6. PubMed ID: 1708325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Povidone-iodine (betadine) in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Michalová K; Moyes AL; Cameron S; Juni BA; Obritsch WF; Dvorak JA; Doughman DJ; Rhame FS
    Cornea; 1996 Sep; 15(5):533-6. PubMed ID: 8862931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor induces the expression of metalloproteinases-1 and -9, but not -2 or -3, in the corneal epithelium.
    Tao Y; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):345-54. PubMed ID: 7843905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of alkali-injured rabbit corneas with a synthetic inhibitor of matrix metalloproteinases.
    Schultz GS; Strelow S; Stern GA; Chegini N; Grant MB; Galardy RE; Grobelny D; Rowsey JJ; Stonecipher K; Parmley V
    Invest Ophthalmol Vis Sci; 1992 Nov; 33(12):3325-31. PubMed ID: 1385350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.